Should people be paid to get the COVID-19 vaccine or booster?

France Nouvelles Nouvelles

Should people be paid to get the COVID-19 vaccine or booster?
France Dernières Nouvelles,France Actualités
  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 55%

A financial incentive can help convince more people to get the vaccine or booster, supporters say. But critics worry a payment can send the wrong message.

“Paying people to take vaccines is worth considering in order to end the pandemic more quickly by protecting the population from COVID-19,” Shah told TODAY in 2020.

“When we worry about payment, it’s because the lure of money might entice people to make bad decisions. In this case, people would be paid to take vaccines that would benefit them and others, which has the potential to be a win-win.”“People should understand that they are part of society. It's like paying people to stop at stop signs,” said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia.

“If you pay people to get vaccinated, the strong implication is it's not safe, there's something wrong, you have to use money to persuade them,” Caplan said. “Historically, we've never paid anybody to vaccinate with routine vaccinations — we've always said they’re safe and they work, and that's why you should use them. You start rewarding them financially, I think many people may get nervous that they can't be safe, they can't work, there must be some reason you have to pay me to get it.”

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

TODAYshow /  🏆 389. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

EU backs Novavax shot as region's fifth COVID-19 vaccineEU backs Novavax shot as region's fifth COVID-19 vaccineThe European Union on Monday approved the use of Novavax's COVID-19 vaccine in people 18 years and older, giving a boost to the U.S. biotech after long delays and paving the way for a fifth shot in the region as the Omicron variant spreads quickly.
Lire la suite »

US COVID-19 map: Tracking cases and deathsUS COVID-19 map: Tracking cases and deathsTrack coronavirus outbreaks across the US and in your state with daily updated maps, total cases and deaths.
Lire la suite »

Chicago theaters cancel holiday performances over COVID-19 concernsChicago theaters cancel holiday performances over COVID-19 concernsMultiple Chicago theaters canceled or postponed performances this weekend due to the new COVID-19 surge. The casualties: Shows in theaters from downtown to the suburbs canceled either out of caution or because cast members and crews tested positive for the virus. Those include (but are not limited to): 'The Nutcracker' (Joffrey Ballet)'Pretty Woman: The Musical' (Broadway in Chicago) Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free'Teatro ZinZa
Lire la suite »

Biden says he was tested for COVID-19, no results yetBiden says he was tested for COVID-19, no results yetU.S. President Joe Biden said he received another COVID-19 test on Wednesday, five days after exposure to the virus from a member of his staff, but has not received the results yet.
Lire la suite »

FDA authorizes 1st COVID-19 pill to protect against severe diseaseFDA authorizes 1st COVID-19 pill to protect against severe diseaseThe Food and Drug Administration on Wednesday authorized the first COVID-19 antiviral pill in the United States to protect against severe disease.
Lire la suite »



Render Time: 2025-03-13 05:22:51